Journal article icon

Journal article

Cultural issues in assessing quality of life in cancer clinical trials.

Abstract:

Over the past decade, there has been significant progress made into the field of quality of life in cancer clinical trials. Many cancer clinical trials now include quality of life as a secondary end-point, but only a very small number of trials include quality of life as a primary end-point. This article reviews and discusses issues that arise when developing a quality of life instrument for use in international cancer clinical trials. We describe problems that arise when trying to establish ...

Expand abstract

Actions


Access Document


Publisher copy:
10.1586/14737167.2.3.261

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Role:
Author
Journal:
Expert review of pharmacoeconomics and outcomes research
Volume:
2
Issue:
3
Pages:
261-267
Publication date:
2002-06-05
DOI:
EISSN:
1744-8379
ISSN:
1473-7167
URN:
uuid:3034ac6f-09c0-4378-bb30-0ab405bccccf
Source identifiers:
374956
Local pid:
pubs:374956

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP